PA
RDY icon

Parallel Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Parallel Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19M Sell
81,864
-6,309
-7% -$85.1K 0.02% 468
2026
Q1 		$1.22M Buy
88,173
+22,331
+34% +$311K 0.02% 407
2025
Q4 		$924K Sell
65,842
-12,858
-16% -$180K 0.02% 468
2025
Q3 		$1.1M Buy
78,700
+260
+0.3% +$3.74K 0.02% 404
2025
Q2 		$1.18M Buy
78,440
+29,375
+60% +$419K 0.02% 374
2025
Q1 		$647K Sell
49,065
-23,725
-33% -$327K 0.01% 506
2024
Q4 		$1.15M Sell
72,790
-70
-0.1% -$1.05K 0.03% 361
2024
Q3 		$1.16M Buy
72,860
+10,750
+17% +$173K 0.03% 358
2024
Q2 		$946K Buy
62,110
+7,350
+13% +$105K 0.02% 373
2024
Q1 		$803K Buy
54,760
+22,190
+68% +$324K 0.02% 405
2023
Q4 		$453K Buy
32,570
+1,885
+6% +$25.2K 0.01% 520
2023
Q3 		$410K Buy
30,685
+8,615
+39% +$117K 0.01% 517
2023
Q2 		$279K Buy
22,070
+1,025
+5% +$12K 0.01% 645
2023
Q1 		$240K Buy
21,045
+5,720
+37% +$61.7K 0.01% 689
2022
Q4 		$159K Sell
15,325
-12,430
-45% -$134K 0.01% 801
2022
Q3 		$291K Buy
27,755
+5,275
+23% +$56.2K 0.01% 551
2022
Q2 		$249K Buy
22,480
+3,090
+16% +$33.6K 0.01% 593
2022
Q1 		$220K Buy
19,390
+1,470
+8% +$16.7K 0.01% 690
2021
Q4 		$234K Sell
17,920
-1,250
-7% -$15.8K 0.01% 688
2021
Q3 		$250K Buy
19,170
+285
+2% +$3.8K 0.01% 637
2021
Q2 		$278K Buy
18,885
+1,000
+6% +$14K 0.01% 563
2021
Q1 		$220K Sell
17,885
-135
-0.7% -$1.73K 0.01% 607
2020
Q4 		$257K Sell
18,020
-2,345
-12% -$31.6K 0.01% 515
2020
Q3 		$283K Buy
20,365
+485
+2% +$5.78K 0.02% 442
2020
Q2 		$210K Sell
19,880
-3,975
-17% -$40.4K 0.01% 526
2020
Q1 		$192K Buy
23,855
+9,810
+70% +$81.8K 0.02% 455
2019
Q4 		$114K Buy
14,045
+5,005
+55% +$39.5K 0.01% 724
2019
Q3 		$68K Buy
9,040
+2,650
+41% +$19.7K 0.01% 868
2019
Q2 		$48K Buy
6,390
+1,165
+22% +$9.16K ﹤0.01% 924
2019
Q1 		$42K Buy
5,225
+3,305
+172% +$25.1K ﹤0.01% 915
2018
Q4 		$14K Buy
1,920
+330
+21% +$2.32K ﹤0.01% 1201
2018
Q3 		$11K Sell
1,590
-250
-14% -$1.67K ﹤0.01% 1410
2018
Q2 		$11K Buy
1,840
+1,015
+123% +$6.4K ﹤0.01% 1309
2018
Q1 		$5K Sell
825
-1,400
-63% -$9.81K ﹤0.01% 1575
2017
Q4 		$17K Buy
2,225
+1,860
+510% +$13.4K ﹤0.01% 1089
2017
Q3 		$3K Sell
365
-1,110
-75% -$7.98K ﹤0.01% 1772
2017
Q2 		$11K Buy
1,475
+1,155
+361% +$9.39K ﹤0.01% 1284
2017
Q1 		$3K Hold
320
– – ﹤0.01% 1696
2016
Q4 		$3K Buy
+320
New +$2.98K ﹤0.01% 1545

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
AIM
ARGA Investment Management Stamford, Connecticut $3.92B AUM 35.93% 1-Year Est. Return

Parallel Advisors's RDY Position: Q2 2026 in Review

Parallel Advisors reduced its Dr. Reddy's Laboratories (RDY) stake by 7.2% in Q2 2026, selling an estimated $85.1K and leaving 81,864 shares worth $1.19M. The position accounts for 0.02% of the portfolio, ranked #468.

Parallel Advisors first reported a position in RDY in Q4 2016 and has held it in 39 quarters since. The position peaked at $1.22M in Q1 2026. 101 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Parallel Advisors held 81,864 shares of Dr. Reddy's Laboratories worth $1.19M as of Q2 2026.
  • Parallel Advisors sold 6,309 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $85.1K.
  • Dr. Reddy's Laboratories made up 0.02% of Parallel Advisors's portfolio in Q2 2026, its #468 holding.
  • Parallel Advisors first reported a position in Dr. Reddy's Laboratories in Q4 2016 and has held it in 39 quarters since.
  • Parallel Advisors's Dr. Reddy's Laboratories position peaked at $1.22M in Q1 2026.
  • 101 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.